Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-021271

CHIEF OPERATING OFFICER sold 138,614 shares at an average $33.20 ($4,602,370)

  • CHIEF OPERATING OFFICER acquired 138,614 shares (option exercise)
  • CHIEF OPERATING OFFICER acquired 752 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2025-07-15 Grant or award 10b5-1 +752 $15.63 $11,754 49,915 D
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Option exercise 10b5-1 +38,928 $10.36 $403,294 88,843 D
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Option exercise 10b5-1 +30,444 $12.97 $394,859 119,287 D
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Option exercise 10b5-1 +32,710 $11.10 $363,081 151,997 D
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Option exercise 10b5-1 +25,896 $11.97 $309,975 177,893 D
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Option exercise 10b5-1 +10,636 $10.76 $114,443 188,529 D
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Sale 10b5-1 −138,064 $33.20 $4,583,725 50,465 D
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Sale 10b5-1 −550 $33.90 $18,645 49,915 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Option exercise · Share Option 10b5-1 −38,928 0 D
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Option exercise · Share Option 10b5-1 −30,444 16,694 D
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Option exercise · Share Option 10b5-1 −32,710 32,710 D
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Option exercise · Share Option 10b5-1 −25,896 39,524 D
Tessari Eben CHIEF OPERATING OFFICER 2025-08-05 Option exercise · Share Option 10b5-1 −10,636 31,908 D
Open-market sales · 138,614 sh · avg $33.20 · $4,602,370
Loading xslF345X05/form4-08072025_080818.xml…